Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B

Journal of Inherited Metabolic Disease

Volumn 36, Issue 1, 2013, Pages 123-127

  Wasserstein, Melissa ^a   Godbold, James ^a   McGovern, Margaret M ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MINERAL; BONE SCINTISCANNING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HIP; HUMAN; IMAGE ANALYSIS; LUMBAR SPINE; MALE; NIEMANN PICK DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; SCHOOL CHILD; SCORING SYSTEM; SPLEEN SIZE; SPLENOMEGALY;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BONE DENSITY; CHILD; CHILD, PRESCHOOL; FEMALE; FEMUR NECK; HUMANS; INFANT; LUMBAR VERTEBRAE; MALE; NIEMANN-PICK DISEASE, TYPE A; NIEMANN-PICK DISEASE, TYPE B; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84872602670     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-012-9503-0     Document Type: Article

References (25)

1. Arenz C (2010) Small molecule inhibitors of acid sphingomyelinase. Cell Physiol Biochem 26(1):1-8
2. Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ (2002) Bone complications in children with Gaucher disease. Br J Radiol 75:A37-A44
3. de Kam D, Smulders E, Weerdesteyn V, Smits-Engelsman BCM (2009) Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials. Osteoporos Int 20(12):2111-25 print
4. Deegan PB, Pavlova E, Tindall J et al. (2011) Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Med Jan 90(1):52-60
5. DeMayo RF, Haims AH, McRae MC, Yang R, Mistry PK (2008) Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher's disease. Am J Rheum 191:115-123
6. Germain DP, Benistan K, Boutouyrie P (2005) Mutschler C (2005) Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease. Clin Genet 68(1):93-5
7. Goker-Alpan O (2011) Therapeutic approaches to bone pathology in Gaucher disease: past, present and future. Molec Genet Metab 104(4):438-447
8. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford
9. Lin JH (1996) Biphosphonates: a review of their pharmacologic properties. Bone 18(2):72-85
10. Makoto Y, Watanabe Y, Tokunaga Y et al. (2008) Roles of specific cytokines in bone remodeling and hematopoiesis in Gaucher disease. Ped Int 49:959-965
11. McGovern MM, Aron A, Brodie S, Desnick RJ, Wasserstein MP (2006) The natural history of Niemann Pick disease type A. Neurology 66(2):228-232
12. McGovern MM, Wasserstein MP, Bembi B et al. (2008) A cross sectional study of disease manifestations in Niemann Pick disease yype B. Pediatrics 122(2):e341-349
13. Mersebach H, Johansson JO, Rasmussen AK et al. (2007) Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density. Genet Med 12:812-8
14. Mistry PK, Liu J, Yang M et al. (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
15. Mistry PK, Weinreb NJ, Kaplan P et al. (2011) Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults. Blood Cells Mol Dis 46(1):66-72
16. NIH Consensus Development Panel (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795
17. Roth AG, Drescher D, Yang Y et al. (2009) Potent and selective inhibition of acid sphingomyelinase by bisphosphonates. Angewandte Chemie 48:7560-7568
18. Russell S, Crawford B, Morgane C, Diven D, Yarbor L (2011) Denosumab: a review of its pharmacology and clinical implications. Contemp Oncol 3(1)
19. Sacre K, Lidove O, Giroux B et al. (2010) Bone and joint involvement in Fabry disease. Scand J Rheum 39:171-174
20. Schuchman EH, Desnick RJ (2001) Niemann Pick disease types A and B: acid sphingomyelinase deficiencies. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. McGraw Hill, New York, pp 3589-3610
21. Stevenson DA, Moyer-Mileur LJ, Murray M et al. (2007) Bone mineral density in children and adolescents with neurofibromatosis type 1. J Ped 150(1):83-88
22. van Breemen MJ, de Fost M, Voerman JS et al. (2007) Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease. Biochim Biophys Acta 1772(7):788-796
23. Volders P, Van Hove J, Lories RJU et al. (2002) Niemann-Pick disease type B: an unusual clinical presentation with multiple vertebral fractures. Am J Med Genet 109(1):42-51
24. Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi B (2002) Skeletal aspects of Gaucher disease: a review. Br J Rad 75:A2-A12
25. Wenstrup RJ, Bailey L, Grabowski GA et al. (2004) Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy. Blood 104:1253-1257